Advertisement
Home 2016 January

Monthly Archives: January 2016

Pulse pressure is associated with multiple adverse cardiovascular outcomes

Pulse Pressure Linked to Multiple Adverse Cardiovascular Outcomes

0
After adjustment for multiple variables, PP linked to all outcomes except stroke, cardiovascular death
For healthy subjects

Prednisolone Therapy Induces Procoagulant State

0
Ten days of treatment linked to increase in peak thrombin, velocity index, PAI-1, and vWF
In a clinical guideline published online Jan. 26 in the Annals of Internal Medicine

ACP Presents High-Value Care Advice for Hematuria

0
Seven pieces of high-value care advice presented to clinicians for evaluating patients with hematuria
Overweight and obese individuals are at increased risk of sudden cardiac death (SCD) and non-SCD

Overweight, Obesity Linked to Risk of Sudden Cardiac Death

0
Increased risk of SCD with electrocardiogram abnormalities, even in normal-weight individuals
A single-stage procedure can provide simultaneous treatment for cellulite and lipodystrophy

Single-Stage Procedure Treats Cellulite, Lipodystrophy

0
Approach provides simultaneous treatment with Nd:YAG laser, side-firing fiber-optic laser system
For patients with spasmodic senile entropion

Botulinum Toxin Successfully Treats Senile Entropion

0
Entropion resolved at seven days after injection of botulinum toxin into orbicularis oculi muscle
For patients with early-stage small-cell lung cancer undergoing resection

Adjuvant Therapy Ups Survival in Small-Cell Lung Cancer

0
Improved survival for chemotherapy with or without cranial irradiation versus surgery alone
Use of ultrasonography features can help identify the risk of malignancy for patients with an adnexal tumor

Risk of Malignancy Can Be Quantified Using Simple Rules

0
Ultrasonography features can identify the risk of malignancy in patients with adnexal masses
Ivacaftor is a potential new treatment to offer children aged 2 years and older with cystic fibrosis and a CFTR gating mutation

Ivacaftor Appears Efficacious, Safe for Younger CF Patients

0
Researchers find treatment works and is well tolerated in 2- to 5-year-olds with cystic fibrosis

ASCO Gastrointestinal Cancers Symposium, Jan. 21-23

0
The ASCO 2016 Gastrointestinal Cancers Symposium The American Society of Clinical Oncology's 12th annual Gastrointestinal Cancers Symposium was held from Jan. 21 to...